Evidence map›Paper›PMID 41788331›Full record

ReviewFrontiers in microbiology2026

Fungi between threat and promise: global perspectives on health and innovation.

Hao Li, Yu-Yen Yang, Santosh Chokkakula, Kuppusamy Sathishkumar, Mohammed Mujahid Alam, Abdullah G Al-Sehemi, Xiaoxi Zhang, Siomui Chong, Gnanaprakash Jeyaraj

Abstract readReview
In one paragraph

Review in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Hybrid Whole-Genome Sequencing ofInternational journal of molecular sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hao Li *Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, China.
Yu-Yen Yang *Dr. Pong Dermatologic and Aesthetic Clinic, Taipei, Taiwan, China.
Santosh ChokkakulaDepartment of Microbiology, Chungbuk National University College of Medicine and Medical Research Institute, Cheongju, Chungbuk, Republic of Korea.
Kuppusamy SathishkumarDepartment of Biotechnology, Rathinam College of Arts and Science, Coimbatore, Tamil Nadu, India.
Mohammed Mujahid AlamDepartment of Chemistry, College of Science, King Khalid University, Abha, Saudi Arabia.
Abdullah G Al-SehemiDepartment of Chemistry, College of Science, King Khalid University, Abha, Saudi Arabia.
Xiaoxi ZhangDepartment of Dermatology, The First Affiliated Hospital of Jinan University and Jinan University Institute of Dermatology, Guangzhou, China.
Siomui ChongDepartment of Dermatology, The First Affiliated Hospital of Jinan University and Jinan University Institute of Dermatology, Guangzhou, China.
Gnanaprakash JeyarajSaveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Kancheepuram, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fungi play a dual role as indispensable ecological engineers and as major agents of disease in humans, animals, and plants. Recent estimates highlight their substantial impact, with millions of invasive infections annually and severe agricultural losses threatening food security. At the same time, fungi underpin ecosystem services such as decomposition, soil aggregation, and carbon sequestration, while also serving as prolific sources of enzymes, metabolites, and sustainable biomaterials. Advances in single-cell and spatial omics, cryo-electron microscopy, AlphaFold-based structural predictions, and machine learning applied to biosynthetic gene clusters are transforming the study of fungal pathogenicity, symbiosis, and metabolism. These approaches are shifting fungal research from descriptive biology toward predictive, translational pipelines that connect mechanistic insights to drug discovery, resistance management, and biotechnological innovation. Nevertheless, challenges remain, including antifungal resistance, climate-driven emergence of new pathogens, limited therapeutic options, and bottlenecks in scaling fungal applications for sustainability. Addressing these requires integrated One Health strategies that bridge clinical, agricultural, and environmental perspectives. By uniting structural biology, omics, genome editing, and computational tools within a global framework, fungal biology can be harnessed not only to mitigate emerging risks but also to drive innovations in medicine, agriculture, and green technologies.

Indexed as

antifungal resistancebiotechnologyclimate resiliencefungal pathogenicityOne Health

Identifiers

PMID41788331
PMCPMC12957183

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.